As many of you may be getting questions or have concerns about your compliance and changing rules to the DSCSA and Pharma specific issues,
We have created this list to outline how the MDS system will help you address these challenges.
The goal of this email list is to point out our suggested best (business) practices.
While we do not enforce or force you to follow these rules, this list is intended more as a guide to allow you to decide internally how you might want to update your practices and systems.
Please note this is a combination of information collected from various conferences and Industry Groups HDA, NCPA, HIDA, FDA, etc.
However since the FDA is the current enforcement agency in charge we have used their site as the model for compliance.
For those with more specific needs please email email@example.com
And we will reach out directly.
* indicates required